Living Well with Myeloma: IMF's Expert Panel Answers Your Top Concerns
treatment options
click on the image above to watch the teleconference
(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)
IMF's Expert Panel Answers Your Top Concerns
Dr. Brian G.M. Durie
Chairman of the Board
International Myeloma Foundation
Dr. Rafat Abonour
Indiana University Simon Cancer Center
Indianapolis, IN
Dr. Vincent Rajkumar
Mayo Clinic
Rochester, MN
This teleconference is sponsored by an educational grant from:
Amgen, Bristol-Myers Squibb, Celgene Corporation, Janssen, and Takeda Oncology
Previous Post
How important is the new IMWG response criteria, which includes the use of minimal residual disease testing?
Next Post
What should be done to carefully monitor myeloma in the remission phase?




